Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Validation of LRG1 as a potential biomarker for detection of epithelial ovarian cancer by a blinded study.

Wu J, Yin H, Zhu J, Buckanovich RJ, Thorpe JD, Dai J, Urban N, Lubman DM.

PLoS One. 2015 Mar 23;10(3):e0121112. doi: 10.1371/journal.pone.0121112. eCollection 2015.

2.

JAK2 expression is associated with tumor-infiltrating lymphocytes and improved breast cancer outcomes: implications for evaluating JAK2 inhibitors.

Miller CP, Thorpe JD, Kortum AN, Coy CM, Cheng WY, Ou Yang TH, Anastassiou D, Beatty JD, Urban ND, Blau CA.

Cancer Immunol Res. 2014 Apr;2(4):301-6. doi: 10.1158/2326-6066.CIR-13-0189. Epub 2014 Jan 15.

3.

Impact of screening test performance and cost on mortality reduction and cost-effectiveness of multimodal ovarian cancer screening.

Drescher CW, Hawley S, Thorpe JD, Marticke S, McIntosh M, Gambhir SS, Urban N.

Cancer Prev Res (Phila). 2012 Aug;5(8):1015-24. doi: 10.1158/1940-6207.CAPR-11-0468. Epub 2012 Jul 2.

4.

Potential role of HE4 in multimodal screening for epithelial ovarian cancer.

Urban N, Thorpe JD, Bergan LA, Forrest RM, Kampani AV, Scholler N, O'Briant KC, Anderson GL, Cramer DW, Berg CD, McIntosh MW, Hartge P, Drescher CW.

J Natl Cancer Inst. 2011 Nov 2;103(21):1630-4. doi: 10.1093/jnci/djr359. Epub 2011 Sep 14.

5.

Irradiation effect after mastectomy on breast cancer recurrence in patients presenting with locally advanced disease.

Taras AR, Thorpe JD, Morris AD, Atwood M, Lowe KA, Beatty JD.

Am J Surg. 2011 May;201(5):605-10. doi: 10.1016/j.amjsurg.2011.01.017.

PMID:
21545907
6.

Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study.

Anderson GL, McIntosh M, Wu L, Barnett M, Goodman G, Thorpe JD, Bergan L, Thornquist MD, Scholler N, Kim N, O'Briant K, Drescher C, Urban N.

J Natl Cancer Inst. 2010 Jan 6;102(1):26-38. doi: 10.1093/jnci/djp438. Epub 2009 Dec 30.

7.

Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery.

Pitteri SJ, JeBailey L, Fa├ža VM, Thorpe JD, Silva MA, Ireton RC, Horton MB, Wang H, Pruitt LC, Zhang Q, Cheng KH, Urban N, Hanash SM, Dinulescu DM.

PLoS One. 2009 Nov 19;4(11):e7916. doi: 10.1371/journal.pone.0007916.

8.

Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.

Shah CA, Lowe KA, Paley P, Wallace E, Anderson GL, McIntosh MW, Andersen MR, Scholler N, Bergan LA, Thorpe JD, Urban N, Drescher CW.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1365-72. doi: 10.1158/1055-9965.EPI-08-1034.

9.

Systematic evaluation of candidate blood markers for detecting ovarian cancer.

Palmer C, Duan X, Hawley S, Scholler N, Thorpe JD, Sahota RA, Wong MQ, Wray A, Bergan LA, Drescher CW, McIntosh MW, Brown PO, Nelson BH, Urban N.

PLoS One. 2008 Jul 9;3(7):e2633. doi: 10.1371/journal.pone.0002633.

10.

Use of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies) in bead-based ELISA.

Scholler N, Lowe KA, Bergan LA, Kampani AV, Ng V, Forrest RM, Thorpe JD, Gross JA, Garvik BM, Drapkin R, Anderson GL, Urban N.

Clin Cancer Res. 2008 May 1;14(9):2647-55. doi: 10.1158/1078-0432.CCR-07-1442.

11.

Effects of blood collection conditions on ovarian cancer serum markers.

Thorpe JD, Duan X, Forrest R, Lowe K, Brown L, Segal E, Nelson B, Anderson GL, McIntosh M, Urban N.

PLoS One. 2007 Dec 5;2(12):e1281.

12.

Oral cancer: third party reimbursement.

Thorpe JD.

Ill Dent J. 1988 Sep-Oct;57(5):350-2. No abstract available.

PMID:
3248799
13.

A strong case for state boards.

Thorpe JD.

Dent Stud. 1976 Jun;54(9):42-3. No abstract available.

PMID:
1078242
14.

Continuing education: needs, delivery methods.

Thorpe JD.

Dent Stud. 1976 May;54(8):94, 97. No abstract available.

PMID:
1077967
15.

Fluoride and its uses.

Thorpe JD.

Ill Dent J. 1974 Oct;43(10):648-63. No abstract available.

PMID:
4529830
16.

Multiple primary neoplasms of the lung.

Leafstedt SW, Sweetman WR, Chester CL, Thorpe JD.

J Thorac Cardiovasc Surg. 1968 May;55(5):626-33. No abstract available.

PMID:
5651573
17.

Granulomatous orchitis.

SPJUT HJ, THORPE JD.

Am J Clin Pathol. 1956 Feb;26(2):136-45. No abstract available.

PMID:
13292400
18.

Presentation of case.

THORPE JD.

J Am Med Assoc. 1955 Sep 3;159(1):32-3. No abstract available.

PMID:
13242410
19.

Presentation of case.

THORPE JD.

J Am Med Assoc. 1955 Aug 13;158(15):1362-3. No abstract available.

PMID:
13242357
20.

Metastatic cancer in the thyroid gland; report of four cases.

THORPE JD.

West J Surg Obstet Gynecol. 1954 Nov;62(11):574-6. No abstract available.

PMID:
13217252

Supplemental Content

Loading ...
Support Center